You are here

Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Jundiai, Sao Paulo, Brazil
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Panic Disorders
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Meet DSM IV criteria for Panic Disorder (with or without agoraphobia) for at least 3
months before study day 1.

- Have a minimum of 8 full-symptom panic attacks during the 4 weeks before the screening
visit.

- Provide a written informed consent

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Treatment with Venlafaxine within 6 months of study day 1, as well Paroxetine

- Known hypersensitivity to Venlafaxine or related compounds as well to Paroxetine.

- Psychopharmacologic drugs within 14 days of study day 1

NCT00195598
Pfizer
Completed
Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Panic Disorders
NCT00195598
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now